about
A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanomaHigh expression of TIMP-1 in human breast cancer tissues is a predictive of resistance to paclitaxel-based chemotherapy.TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activationTIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patientsTIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cellsDeficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations.TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain.Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatmentTIMP-1 deficiency subverts cell-cycle dynamics in murine long-term HSCs.Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release.Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions.Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2.A microfluidic device for label-free, physical capture of circulating tumor cell clusters.Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancerProteomics analysis of bodily fluids in pancreatic cancerSurgical removal of the parametrial fat pads stimulates apoptosis and inhibits UVB-induced carcinogenesis in mice fed a high-fat dietPrognostic significance of tissue inhibitor of metalloproteinase-1 in breast cancer.TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformationTIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signalingClinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review.Cytokine functions of TIMP-1.The Inhibitory Effect of C-phycocyanin Containing Protein Extract (C-PC Extract) on Human Matrix Metalloproteinases (MMP-2 and MMP-9) in Hepatocellular Cancer Cell Line (HepG2).TIMPs: versatile extracellular regulators in cancer.TIMP-1 signaling via CD63 triggers granulopoiesis and neutrophilia in mice.Down-regulation of TIMP-1 inhibits cell migration, invasion, and metastatic colonization in lung adenocarcinoma.The estrogen receptor alpha-derived peptide ERα17p (P(295)-T(311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status.Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator.Immunohistochemical expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in invasive breast carcinomaDBCG: the Danish Breast Cancer Cooperative Group--a 30-year struggle for better breast cancer treatment in Denmark.Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node.TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway.Invasive aspergillosis promotes tumor growth and severity in a tumor-bearing mouse model
P2860
Q21245488-E277FC6D-E078-46C8-9AC3-9ADF071B2023Q27851775-0CF4C242-D785-4770-AB2F-EB98EF367965Q27852459-D195035D-8A83-406A-8201-42DD4FDA8032Q28483470-D556F7DC-2CDD-4C5C-9947-F85BAB354907Q33553922-DC369122-76DE-4585-BE15-78F8E7703175Q33880656-E1671FD9-80B1-4C6D-8AB5-C628C808D983Q34224634-9781AAC3-15E2-45C3-BA3C-59F295940D9DQ34258918-717075EB-6542-4EA3-85EE-5412E30C30E2Q34305749-15B65CB0-D807-4BBA-876B-0A7A4DF225C0Q34775164-4DAC809A-8FB7-431E-96DD-12381B19AF49Q35067597-3D494427-3F38-4900-BAD0-6A9509ABFB22Q35257111-69AC3327-CBFE-440C-8B39-4F5C9DC12666Q35290842-1C895D28-268F-4168-8E3C-4143C53576D1Q35575176-9C34DB76-3967-4BFD-8669-0095224AFC10Q35608684-8914A4D7-BEBD-4012-967B-F7EBA4C30708Q35772248-B9153AB4-DFAF-49B8-878C-817354AF2A7BQ35812039-5DA30EA2-2470-471A-A887-16B63108A0E7Q35854297-35710C1C-4CC5-4719-971E-43D433290AFFQ35920900-FE14A660-2514-46D3-A18F-64611AB2B5A8Q36061494-8EE4038D-1593-4A3C-B76F-7217860BB29EQ36231009-484B15CD-C09F-41A3-BA89-183FF2CB54E5Q37267647-A095F5FD-8FC8-4D81-A9DD-1C8B7C443F57Q37429861-02184BCE-42FE-4178-A301-622F5D3609D6Q37644878-26ADE8C1-7896-4241-B950-1325E4EA60C3Q37709259-E57AAFA2-6E2E-41DD-9305-C7490F27675FQ37809871-555E70F4-188A-4D61-A27F-4CD53FB088F0Q38119975-AF872372-F536-448D-B56F-4720866973B3Q38132068-27B4ED48-AF93-4D26-8C0D-8C2A82375DFAQ38709646-249C3CD2-D717-4E4F-A1D3-DF7A16052002Q38785433-A33E02C4-03D6-428B-B66E-9473D92A06D8Q38871864-7B27124F-D377-48FF-8888-84FD18ACC8D2Q38921163-A91815C0-FAEF-4DB2-BC58-8A3C9052B1E0Q39619285-932E2B40-BB7F-45FE-8452-3B093A5615FBQ39782448-91219CD6-4B8A-4DAE-8F2B-7034877145C9Q42375660-99D3D03D-165A-4008-BD33-8BEF9041821EQ50547499-393A1BB6-13D2-4BA1-A68D-2E57F1538151Q54549875-FA323558-EBDC-4DDC-93A2-641359939DF7Q55251047-DDF842EF-880A-4151-AF50-F015D57DA2ABQ57905254-3769DF7A-928F-4F19-BA7A-5750CE08D0AF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TIMP-1 as a tumor marker in breast cancer--an update.
@en
TIMP-1 as a tumor marker in breast cancer--an update.
@nl
type
label
TIMP-1 as a tumor marker in breast cancer--an update.
@en
TIMP-1 as a tumor marker in breast cancer--an update.
@nl
prefLabel
TIMP-1 as a tumor marker in breast cancer--an update.
@en
TIMP-1 as a tumor marker in breast cancer--an update.
@nl
P2093
P2860
P1433
P1476
TIMP-1 as a tumor marker in breast cancer--an update.
@en
P2093
Anne-Sofie Schrohl
Henning Mouridsen
Nils Brünner
Sidse O Würtz
P2860
P304
P356
10.1080/02841860802022976
P577
2008-01-01T00:00:00Z